Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma-Reference-Cited by-同舟云学术

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma

Published:2015-09-09 Issue:3 Volume:18 Page:401-407
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Furtner Julia,Schöpf Veronika,Seystahl Katharina,Le Rhun Emilie,Rudà Roberta,Roelcke Ulrich,Koeppen Susanne,Berghoff Anna Sophie,Marosi Christine,Clement Paul,Faedi Marina,Watts Colin,Wick Wolfgang,Soffietti Riccardo,Weller Michael,Preusser Matthias

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/3/401/7640780/nov183.pdf

Reference25 articles.

1. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry

2. New Editorial Team for Neuro-Oncology

3. Louis DN Ohgaki H Wiestler OD WHO Classification of Tumors of th Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007.

4. Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

5. Temozolomide for treatment-resistant recurrent meningioma;Chamberlain;Neurology,2004

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Related mechanisms, current treatments, and new perspectives in meningioma;Genes, Chromosomes and Cancer;2024-05

2. 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas;Neuro-Oncology;2024-03-07

3. Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria;Neuro-Oncology Advances;2024-01-01

4. Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications;Cancers;2023-09-12

5. Case Report: Recurrent meningioma with multiple metastases;Frontiers in Oncology;2023-07-17